The European Immunogenicity Platform (EIP) is a central meeting place for scientists and biopharmaceutical companies in Europe. The goal of the EIP is to improve knowledge and expertise in immunogenicity. This is achieved through collaboration between scientists and industry experts. The EIP works with companies, institutes, and professionals involved in immunogenicity assessment tools and research. They also collaborate with those who service the biotechnology community. The EIP focuses on interacting with regulatory authorities and creating recommendations regarding immunogenicity. Additionally, they aim to stimulate research on the clinical and non-clinical effects of unwanted immunogenicity. They believe collaboration between academia and pharmaceutical companies is important. The EIP was founded in 2007 by immunogenicity experts.